Re: NEW ARTICLE: All going to plan at Mi... Hi Blanketstacker, yes Dillistone does appeal as I already hold some of these shares. I also had a quick look at Scisys and this also looks like an attractive company but with my ultra cautious (or perhaps over cautious) approach I think the profit margins might be a bit on the thin side for my portfolio. Thanks for pointing these out.
Re: NEW ARTICLE: All going to plan at Mi... Hi pharma. I agree with you totally. Welcome aboard. If you like this one, do SSY or DSG appeal at all?
Re: NEW ARTICLE: All going to plan at Microg... Agree with this article. I have been monitoring ths company for a while and have decided to take the plunge now as all the figures seem to be going in the right direction. I like the cash generating nature of this business and the conservative style of management, which includes returning cash to shareholders when not needed for acquisitions. The only negative I can see is that the longstanding chairman is leaving soon but the company's other management seem to have been in post for quite a while so they should know how to continue the good work.
NEW ARTICLE: All going to plan at Microgen "LSE:MCGN:Microgen built on its strong start to 2015, finishing the first half with a flourish to deliver better-than-expected results at its fast-growing Aptitude Software business. There's good visibility on revenue for the rest of this year, ..."[link]
Re: Buying time? Thanks Cane. I had overlooked that. The institutional investors do not seem to be willing to take up too many of these at the moment. We willundoubtedly see lower now. I topped uptoday, but will gather some more powder for around a quid!
Re: Buying time? Agree with your sentiments about the company, however, the Chairman holds 7.11% of the company and is now retiring. He wants to realise his investment and is working with the firms brokers to place his shares. Until the shares are placed I imagine the sp will drift down and will only move up once the shares are placed. As always DYOR
Buying time? Available at 112 or below, givingER = 11.5Price to book = 1.16Yield = 3% (covered x2)Forward PEG 0.36Very positive update last month.Excellent management team in place.A small recent acquisition and more to come.Cash in the bank and no debt, despite recent return of value to investors.This strikes me as being worth at least 130, so a decent upside here of c15% and the dividend in the meantime. Any comments or ideas please?
NEW ARTICLE: Microgen exceeds own expectations "LSE:MCGN:Microgen, a provider of software and other services to the banking sector, has had a better start to the year than it did in 2014. In fact, the results beat management's expectations and plans for the current year, and there's a real ..."[link]
Is this worth buying now? Peliminary results last week show:ROCE 42%Operating margin 49%EPS 5.5pNet cash £24.6mThe PER is a little high at 17 and there has been a 5% decline in revenue, but there is an acceptable yield of c2.8%, and a forthcoming 'return of value' at 27p per share (subject to consolidation). Does anyone reckon this is worth buying now, or should we ait and see?
27 pence a share return!! Very nice, MCGN deliver again.
Results may be this week nm.
Re: Re: Agreed!
Re: Re: Yes, am hoping for c25p per share at the top end of the range given, why would a company mention £20m and then under deliver by returning less.I know many people see a return of cash as a sign that a company has run out of ideas and I was disappointed with their strategic review, but I am quite happy to receive c3% divi on a steady company and get the occasional sizable special divi.
Re: Re: so according to iii there are about 75M shares in issue and MCGN are returning £15M so that would be about 20P per share, possibly more??
Re: Re: £15-20m return of cash to shareholders announced this morning.